Essential hyaluronan structure for binding with hyaluronan-binding protein (HABP) determined by glycotechnological approach

2021 ◽  
Vol 251 ◽  
pp. 116989
Author(s):  
Shinichiro Suto ◽  
Ikuko Kakizaki ◽  
Yota Tatara ◽  
Masahiko Endo
2020 ◽  
Vol 9 (1) ◽  
pp. 1-11
Author(s):  
Zijun Yang ◽  
Shu Song ◽  
Wenchao Yin ◽  
Xin Qian ◽  
Qiang Yu ◽  
...  

Author(s):  
Masahiro Momoeda ◽  
Susana de Vega ◽  
Haruka Kaneko ◽  
Chiho Yoshinaga ◽  
Masayuki Shimoda ◽  
...  

2019 ◽  
Vol 20 (22) ◽  
pp. 5804 ◽  
Author(s):  
Hiroyuki Yoshida ◽  
Yasunori Okada

Photoaged skin is characterized clinically by apparent manifestations such as wrinkles and sagging, and histologically by an accumulation of abnormal elastin and a severe loss of collagen fibers in the dermis. Quantitative and qualitative alterations in elastin and collagens are considered to be responsible for the formation of wrinkles and sagging. However, since the integrity of elastin and collagen fibers in the dermis is maintained by their interactions with hyaluronan (HA) and a proteoglycan network structure, HA degradation may be the initial process, prior to the breakdown of the fibrillary components, leading to wrinkles and sagging in photoaged skin. We have recently discovered a new HA-degrading mechanism mediated by HYBID (hyaluronan binding protein involved in hyaluronan depolymerization), alias KIAA1199/CEMIP, in human skin fibroblasts, and examined the implication of HYBID for skin photoaging. In this review, we give an overview of the characteristics of HYBID and its prospective roles in HA turnover in normal skin and excessive HA degradation in photoaged skin. In addition, we describe our data on the inhibition of HYBID activity and expression by plant extracts in skin fibroblasts; and propose novel strategies to prevent or improve photoaging symptoms, such as skin wrinkling, by inhibition of HYBID-mediated HA degradation.


2019 ◽  
Vol 12 (1) ◽  
Author(s):  
D. Manjunath ◽  
Sunil B. Kumaraswamy ◽  
Shashidhar Aladhi Venkatakrishniah ◽  
Hitesh Nidumanda Appaiah ◽  
Anil Thomas ◽  
...  

Abstract Objective Management and diagnosis of multiple human cancers remains a challenge and search for a common biomarker is still debatable. In this manuscript we have evaluated the use of monoclonal antibody UNIVmAb, to detect the protein (H11) as a common biomarker for all cancers irrespective of the grade and origin. We have shown by both ELISA and Western Blot that the H11 protein, is a unique hyaluronan binding protein that has not been detected earlier. H11 protein was fractionated in an anion exchange column followed by cibacron blue gel exclusion chromatography. Hyaluronan binding H11 protein reacted with Monoclonal antibody UNIVmAb and b-HA inspite of b-Hyaluronan (biotinylated Hyaluronan) interaction and HA-Oligo (Hyaluronan oligosaccharides) competition from various grades of Human cancers sera. Results ELISA, Western blot and b-Hyaluronan interactions clearly showed an over-expression of UNIVmAb reacted H11 protein in all fifty cancer’s sera when compared with seventy normal sera. UNIVmAb reactive H11 protein can be used as a common biomarker. We believe, UNIVmAb detected H11 protein, is a unique hyaluronan binding protein, that can be used as a common biomarker for all cancers.


2017 ◽  
Vol 86 (6) ◽  
pp. 837-844 ◽  
Author(s):  
Carla Colombo ◽  
Marina Muzza ◽  
Maria Carla Proverbio ◽  
Giulia Ercoli ◽  
Michela Perrino ◽  
...  

2013 ◽  
Vol 110 (14) ◽  
pp. 5612-5617 ◽  
Author(s):  
H. Yoshida ◽  
A. Nagaoka ◽  
A. Kusaka-Kikushima ◽  
M. Tobiishi ◽  
K. Kawabata ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document